Understanding the Truth About APOE4, Cholesterol, and Alzheimer's Risk
- Exploring What APOE Genotypes Really Mean for Brain Health
- Examining the Cholesterol-Brain Connection Beyond the Headlines
- Discovering Evidence-Based Strategies to Address APOE4-Related Risk
Reserve Your Spot for This Groundbreaking Presentation
Exclusive for Live Attendees
Live-Attendee Giveaway!Join us LIVE for a chance to win an exclusive 30-minute consultation with Dr. Goodenowe. One lucky attendee will be selected at random towards the end of the webinar. Disclaimer: This is a purely educational conversation, not intended to diagnose or treat any disease.
Join Dr. Dayan Goodenowe for a direct, science-based discussion about APOE genotypes, cholesterol, and Alzheimer’s disease. This presentation cuts through the fear and confusion to reveal what the research actually shows about APOE4, cholesterol metabolism, and what can be done about elevated risk.
APOE, Cholesterol & Brain Health: Fact vs Fear
If someone has been told they carry the APOE4 gene, the fear can be overwhelming.
APOE4 is often called “the Alzheimer’s gene.” Headlines warn about drastically increased risk. Some people avoid genetic testing altogether because they don’t want to know.
But here’s what most people aren’t being told:
APOE4 does increase Alzheimer’s risk. That part is true.
However, there’s a specific biochemical reason why APOE4 increases risk—and that reason is related to how the body manages and distributes cholesterol.
More importantly, understanding this mechanism means the risk can be addressed.
The problem isn’t the gene itself. The problem is what happens when APOE4 affects cholesterol transport and cellular membrane health in the brain.
And those are things that can be measured, understood, and potentially influenced.
APOE4 does increase Alzheimer’s risk. That part is true.
However, there’s a specific biochemical reason why APOE4 increases risk—and that reason is related to how the body manages and distributes cholesterol.
More importantly, understanding this mechanism means the risk can be addressed.
The problem isn’t the gene itself. The problem is what happens when APOE4 affects cholesterol transport and cellular membrane health in the brain.
And those are things that can be measured, understood, and potentially influenced.
Wednesday, February 18th, 2026 • 4:00 PM Pacific
What Really Happens With APOE4 and Cholesterol
Through decades of biochemical research and genetic studies, scientists have identified specific mechanisms that explain why APOE4 increases Alzheimer’s risk:
- Cholesterol Transport Dysfunction - APOE4 is less efficient at transporting cholesterol to brain cells, leading to cellular membrane deficiencies
- Lipid Metabolism Disruption - APOE4 affects how the brain processes and utilizes essential lipids required for neuronal health
- Inflammatory Activation - APOE4 is associated with increased inflammatory responses in the brain compared to other variants
- Cellular Membrane Integrity - Brain cells require specific lipids (including plasmalogens) for membrane health, and APOE4 can compromise this system
The challenge is that conventional approaches focus on the genetic risk factor itself rather than addressing the underlying biochemical mechanisms that the gene influences.
Why do some APOE4 carriers develop Alzheimer’s while others remain cognitively healthy into their 90s?
Because genetics load the gun, but biochemistry pulls the trigger.
The APOE4 genotype creates vulnerabilities in cholesterol and lipid metabolism. But these vulnerabilities can be identified, measured, and addressed at the biochemical level
The First Step Forward is Understanding What APOE Really Does
Approximately 25% of the population carries at least one APOE4 allele. Alzheimer’s disease affects millions of families worldwide.
Yet most people—even those who know their APOE status—don’t understand what APOE actually does in the body or why certain variants create different risk profiles.
Here’s what’s often missing from the conversation:
APOE is not just “the Alzheimer’s gene.” It’s a protein that plays a critical role in cholesterol transport throughout the body and brain. Different APOE variants (E2, E3, E4) handle cholesterol differently—and these differences have profound implications for brain health.
The story that’s been told about cholesterol and heart disease may have obscured a more important truth: cholesterol is essential for brain function, and how the body manages cholesterol distribution matters enormously for cognitive health.
Understanding APOE variants means understanding cholesterol biochemistry. And understanding cholesterol biochemistry opens up pathways that fear and genetics alone cannot provide.
APOE is not just “the Alzheimer’s gene.” It’s a protein that plays a critical role in cholesterol transport throughout the body and brain. Different APOE variants (E2, E3, E4) handle cholesterol differently—and these differences have profound implications for brain health.
The story that’s been told about cholesterol and heart disease may have obscured a more important truth: cholesterol is essential for brain function, and how the body manages cholesterol distribution matters enormously for cognitive health.
Understanding APOE variants means understanding cholesterol biochemistry. And understanding cholesterol biochemistry opens up pathways that fear and genetics alone cannot provide.
Join Dr. Dayan Goodenowe in this exclusive live presentation as we explore:
- What APOE Actually Does - Understanding the real function of APOE variants and why E2, E3, and E4 create different risk profiles
- The Cholesterol-Brain Connection - Why cholesterol is essential for brain health and what happens when transport systems fail
- Good vs Bad Cholesterol Reconsidered - Whether the conventional story about cholesterol has missed critical nuances about brain health
- The APOE4 Mechanism - The specific biochemical pathways through which APOE4 increases Alzheimer's risk
- Measurable Biomarkers - How to identify metabolic vulnerabilities associated with APOE status and what can be measured
- Cholesterol and Mortality - Do we have the story backwards about cholesterol levels and long-term health outcomes?
Register Now: This Science Changes Everything
Dr. Goodenowe presents research on APOE and cholesterol that challenges conventional understanding and provides clear scientific insights into what APOE4 really means—and what can be done about it.
If someone has APOE4, or if someone is concerned about a family history of Alzheimer’s, this presentation provides knowledge that moves beyond genetic determinism to biochemical possibility.
REGISTER FOR FREE EVENT – FEBRUARY 18th, 4PM PACIFIC
INTRODUCING OUR SPEAKER
Dr. Dayan Goodenowe
Dr. Dayan Goodenowe is a world-renowned neuroscientist whose research into the biochemical mechanisms of disease started in 1990. His curiosity about the biochemistry of life remains as insatiable today as it was over three decades ago.
Dr. Goodenowe invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel biochemical precursors, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, stroke, autism, amyotrophic lateral sclerosis (ALS), schizophrenia, bipolar disorder, depression, and the biological mechanisms of aging.
As the founder of Prodrome Sciences and author of the bestselling book “Breaking Alzheimer’s,” Dr. Goodenowe’s research focuses on identifying and correcting the biochemical imbalances that affect cellular function—long before disease becomes irreversible.
His current focus is to defeat the entropy of aging by creating strategic biochemical and biofunctional reserve capacity in advance of known disease risks, enabling the human body to maintain optimal physical and biological functions.
As the founder of Prodrome Science and author of the bestselling book "Breaking Alzheimer's," Dr. Goodenowe's research focuses on identifying and correcting the biochemical imbalances that affect brain function—long before symptoms become irreversible.
His current focus is to defeat the entropy of aging by creating strategic biochemical and biofunctional reserve capacity in advance of known disease risks, enabling the human body to maintain optimal physical and biological functions.
A Direct Look at APOE4 and What Can Be Done
This presentation offers evidence-based, scientifically-grounded understanding of APOE genotypes and cholesterol metabolism that moves beyond fear to reveal actionable biochemical insights.
What You'll Discover:
- The real function of APOE2, APOE3, and APOE4 and why they matter for brain health
- Why Why APOE4 increases Alzheimer's risk and what specific mechanisms are involved
- How cholesterol transport affects brain cell health and cognitive function
- Whether the conventional wisdom about "good" and "bad" cholesterol is complete
- The essential biomarkers that reveal metabolic vulnerabilities associated with APOE status
- Dr. Goodenowe's vision for circumventing genetic risk through metabolic intervention
Live Webinar Details
Exclusive for Live Attendees
Live-Attendee Giveaway!Join us LIVE for a chance to win an exclusive 30-minute consultation with Dr. Goodenowe. One lucky attendee will be selected at random towards the end of the webinar. Disclaimer: This is a purely educational conversation, not intended to diagnose or treat any disease.
IT'S GOING TO BE A LECTURE YOU WON'T WANT TO MISS
Why Attend This Live Webinar?
- Live Q&A with Dr. Goodenowe on cholesterol, genetics, and Alzheimer's risk
- Exclusive research insights on metabolic approaches to genetic risk
- Chance to receive exclusive attendee offer
- Cutting-edge understanding of cholesterol's role in brain health
- Evidence-based strategies for those concerned about APOE4 status
- Clarity beyond fear - understanding the biochemical mechanisms that create risk
Don't Miss This Groundbreaking Presentation
Whether concerned about personal APOE status, caring for someone with Alzheimer’s disease, or seeking to understand this topic beyond the headlines, this presentation provides direct scientific insights backed by decades of biochemical research.
Dr. Goodenowe will break down the biochemistry of APOE variants, cholesterol metabolism, and brain health in a way that everyone can understand—and reveal why genetic risk does not mean genetic destiny.
GROUNDBREAKING RESEARCH REVEALED
What People Are Saying About Dr. Goodenowe's Work
Dr. Goodenowe's research has completely changed how we understand disease at the biochemical level. His scientific approach provides hope grounded in real science, not speculation.
Finally, someone who explains the mechanisms behind disease in a way that makes sense and empowers us to think differently about health.
I am an Apollo Health Coach with a background in Bio/chem, and when I listened to Dr. Goodenowe's research, I was fascinated, intrigued and blown away. My heart beats for science, and his work has started to 'hang together' in ways that make real sense.
Dr. Goodenowe's approach to biochemistry is revolutionary. He doesn't just talk about treating disease—he addresses the underlying mechanisms that can make a real difference in cellular health.
The Science of Understanding Starts Here
Join hundreds discovering how to address genetic risk through biochemical understanding—moving beyond fear to actionable science.
Wednesday, February 18th, 2025 • 4:00 PM Pacific
This event is presented by Perpetual Health in partnership with Prodrome Sciences. Dr. Goodenowe’s research-based insights are grounded in peer-reviewed science and decades of biochemical research.
This presentation is for educational purposes only and not intended as medical advice. Always consult with qualified healthcare professionals regarding any health concerns or decisions.